Cathepsin D--many functions of one aspartic protease.

For years, it has been held that cathepsin D (CD) is involved in rather non-specific protein degradation in a strongly acidic milieu of lysosomes. Studies with CD knock-out mice revealed that CD is not necessary for embryonal development, but it is indispensable for postnatal tissue homeostasis. Mutation that abolishes CD enzymatic activity causes neuronal ceroid lipofuscinosis (NCL) characterized by severe neurodegeneration, developmental regression, visual loss and epilepsy in both animals and humans. In the last decade, however, an increasing number of studies demonstrated that enzymatic function of CD is not restricted solely to acidic milieu of lysosomes with important consequences in regulation of apoptosis. In addition to CD enzymatic activity, it has been shown that apoptosis is also regulated by catalytically inactive mutants of CD which suggests that CD interacts with other important molecules and influences cell signaling. Moreover, procathepsin D (pCD), secreted from cancer cells, acts as a mitogen on both cancer and stromal cells and stimulates their pro-invasive and pro-metastatic properties. Numerous studies found that pCD/CD level represents an independent prognostic factor in a variety of cancers and is therefore considered to be a potential target of anti-cancer therapy. Studies dealing with functions of cathepsin D are complicated by the fact that there are several simultaneous forms of CD in a cell-pCD, intermediate enzymatically active CD and mature heavy and light chain CD. It became evident that these forms may differently regulate the above-mentioned processes. In this article, we review the possible functions of CD and its various forms in cells and organisms during physiological and pathological conditions.

[1]  F. Jessen,et al.  Cerebrospinal fluid levels of &bgr;-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D gene , 2002, Neuroreport.

[2]  M. Schindl,et al.  Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. , 2004, Gynecologic oncology.

[3]  K. Yoneda,et al.  Expression of transglutaminase 1 in human epidermis. , 1995, The Journal of investigative dermatology.

[4]  G. Conner,et al.  Proteolytic activation of human procathepsin D. , 1991, Advances in experimental medicine and biology.

[5]  Isleifur Olafsson,et al.  Inactivation of human cystatin C and kininogen by human cathepsin D , 1991, FEBS letters.

[6]  R. S. Kiss,et al.  Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux* , 2006, Journal of Biological Chemistry.

[7]  S. Scott,et al.  Cathepsin D-mediated proteolysis of apolipoprotein E: Possible role in Alzheimer’s disease , 2006, Neuroscience.

[8]  A. Samarel,et al.  Susceptibilities of cardiac myofibrillar proteins to cathepsin D-catalyzed degradation. , 1983, American Journal of Physiology.

[9]  Mahindra T. Makhija,et al.  Correlation between inactive cathepsin D expression and retinal changes in mcd2/mcd2 transgenic mice. , 2005, Investigative ophthalmology & visual science.

[10]  H. Rochefort,et al.  Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate / IGF-II receptor , 2005, Breast Cancer Research and Treatment.

[11]  S. Yen,et al.  Degradation of Tau by Lysosomal Enzyme Cathepsin D: Implication for Alzheimer Neurofibrillary Degeneration , 1997, Journal of neurochemistry.

[12]  D. Scherman,et al.  Inhibition of cathepsin D by tripeptides containing statine analogs. , 1999, Biochemical pharmacology.

[13]  J. Kay,et al.  Immunolocalization of cathepsin D in normal and neoplastic human tissues. , 1986, Journal of clinical pathology.

[14]  H. Rochefort,et al.  Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. , 1994, Experimental cell research.

[15]  K. von Figura,et al.  Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific. , 1999, Journal of cell science.

[16]  H. Rochefort,et al.  Cathepsin D in cancer metastasis: A protease and a ligand , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  H. C. Robinson,et al.  Cathepsin D cleaves aggrecan at unique sites within the interglobular domain and chondroitin sulfate attachment regions that are also cleaved when cartilage is maintained at acid pH. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[18]  B. Boehm,et al.  A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A. , 2007, Biochemical and biophysical research communications.

[19]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[20]  V. Laurent-Matha,et al.  A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells , 2001, Oncogene.

[21]  L. Skoog,et al.  The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen. , 2000, European journal of cancer.

[22]  J. W. Bird,et al.  Degradation of myofibrillar proteins by cathepsins B and D. , 1977, The Biochemical journal.

[23]  G. Sadik,et al.  In vitro processing of amyloid precursor protein by cathepsin D. , 1999, The international journal of biochemistry & cell biology.

[24]  J. Eaton,et al.  Prevention of oxidant-induced cell death by lysosomotropic iron chelators. , 2003, Free radical biology & medicine.

[25]  M. Baumann,et al.  A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration , 2000, The EMBO journal.

[26]  B. Dunn,et al.  The two sides of enzyme-substrate specificity: lessons from the aspartic proteinases. , 2000, Biochimica et biophysica acta.

[27]  P. Saftig,et al.  Cathepsin D deficiency is associated with a human neurodegenerative disorder. , 2006, American journal of human genetics.

[28]  S. Foundling,et al.  Human breast milk contains procathepsin D--detection by specific antibodies. , 1993, Biochemistry and molecular biology international.

[29]  R E Cachau,et al.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Rochefort,et al.  Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. , 1986, Endocrinology.

[31]  V. Vetvicka,et al.  Mitogenic function of human procathepsin D: the role of the propeptide. , 1994, The Biochemical journal.

[32]  Y. Hannun,et al.  Ceramide and apoptosis. , 1999, Trends in biochemical sciences.

[33]  P. Eagles,et al.  Studies using a fluorescent analogue of kinesin , 1991, Journal of Cell Science.

[34]  E. Ring,et al.  Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. An immunohistochemical study. , 1976, Arthritis and rheumatism.

[35]  Marcel Garcia,et al.  Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells , 2002, Oncogene.

[36]  P. Mecocci,et al.  Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease , 2006, Journal of the Neurological Sciences.

[37]  K. Roberg,et al.  Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. , 1999, Free radical biology & medicine.

[38]  D. Leake Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions? , 1997, Atherosclerosis.

[39]  V. Vetvicka,et al.  Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[40]  R. Jacob,et al.  The catalytically inactive precursor of cathepsin D induces apoptosis in human fibroblasts and HeLa cells , 2007, Journal of cellular biochemistry.

[41]  V. Laurent-Matha,et al.  Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. , 1998, Journal of cell science.

[42]  N. Taniguchi,et al.  Elevated activity and increased mannose-6-phosphate in the carbohydrate moiety of cathepsin D from human hepatoma. , 1988, Cancer research.

[43]  S. Stevanović,et al.  Cathepsin D Is Present in Human Eccrine Sweat and Involved in the Postsecretory Processing of the Antimicrobial Peptide DCD-1L* , 2006, Journal of Biological Chemistry.

[44]  G. Coetzee,et al.  Cathepsin-D-dependent initiation of the hydrolysis by lysosomal enzymes of apoprotein B from low-density lipoproteins. , 1980, European journal of biochemistry.

[45]  J. Crissman,et al.  Histologic assessment of cathepsin D in osteoarthritic cartilage. , 1986, Clinical and experimental rheumatology.

[46]  A. Hasilik,et al.  A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells. , 2003, The Biochemical journal.

[47]  M. Baumann,et al.  Congenital ovine neuronal ceroid lipofuscinosis--a cathepsin D deficiency with increased levels of the inactive enzyme. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[48]  T. Holzman,et al.  Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. , 1994, The Journal of biological chemistry.

[49]  G. Miyamoto,et al.  Proteases involved in the metabolic degradation of human interleukin-1beta by rat kidney lysosomes. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[50]  K. von Figura,et al.  Enhanced degradation of cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline. , 1984, Archives of biochemistry and biophysics.

[51]  C. Peters,et al.  Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. , 1995, EMBO Journal.

[52]  E. Agostinelli,et al.  Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review). , 2007, International journal of oncology.

[53]  H. Du,et al.  Lysosomal Enzymes Are Released From Cultured Human Macrophages, Hydrolyze LDL In Vitro, and Are Present Extracellularly in Human Atherosclerotic Lesions , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[54]  S. Kornfeld,et al.  Lysosomal enzyme targeting. , 1990, Biochemical Society transactions.

[55]  L. Juliano,et al.  α1-Antichymotrypsin and Kallistatin Hydrolysis by Human Cathepsin D , 2000, Journal of protein chemistry.

[56]  P. Saftig,et al.  Altered Regulation of Phosphatidylinositol 3-kinase Signaling in Cathepsin D-Deficient Brain , 2007, Autophagy.

[57]  A. Mizuno,et al.  Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. , 2006, Journal of biochemistry.

[58]  V. Vetvicka,et al.  Depletion of procathepsin D gene expression by RNA interference – A potential therapeutic target for breast cancer , 2007, Cancer biology & therapy.

[59]  R. Baumgrass,et al.  Identification of Peptide Fragments Generated by Digestion of Bovine and Human Osteocalcin with the Lysosomal Proteinases Cathepsin B, D, L, H, and S , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[60]  F. Egberts,et al.  Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation , 2004, Journal of Cell Science.

[61]  I. Silver,et al.  Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism , 1997, Clinical & Experimental Metastasis.

[62]  G. Berchem,et al.  Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis , 2002, Oncogene.

[63]  M. Fusek,et al.  Two crystal structures for cathepsin D: the lysosomal targeting signal and active site. , 1993, The EMBO journal.

[64]  N. Gebbia,et al.  Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors. , 1994, In vivo.

[65]  D. Neary,et al.  Genetic associations between cathepsin D exon 2 C→T polymorphism and Alzheimer’s disease, and pathological correlations with genotype , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[66]  A. Noël,et al.  Catalytically inactive human cathepsin D triggers fibroblast invasive growth , 2005, The Journal of cell biology.

[67]  I. Arany,et al.  Response of keratinocytes from normal and psoriatic epidermis to interferon‐γ differs in the expression of zinc‐α2‐glycoprotein and cathepsin D , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  Mingde Zhao,et al.  Sphingosine-induced apoptosis is dependent on lysosomal proteases. , 2001, The Biochemical journal.

[69]  V. Vetvicka,et al.  Anti‐human procathepsin D activation peptide antibodies inhibit breast cancer development , 1999, Breast Cancer Research and Treatment.

[70]  A. Suzuki,et al.  Cleavage of connectin by calpain and cathepsin D. , 1995, Bioscience, biotechnology, and biochemistry.

[71]  T. Maudelonde,et al.  CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER , 1989, The Lancet.

[72]  J. Trojanowski,et al.  Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.

[73]  L. Mazzucchelli,et al.  Cathepsin D Specifically Cleaves the Chemokines Macrophage Inflammatory Protein-1α, Macrophage Inflammatory Protein-1β, and SLC That Are Expressed in Human Breast Cancer , 2003 .

[74]  V. Vetvicka,et al.  Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy. , 2007, International journal of oncology.

[75]  Carlo Follo,et al.  Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. , 2006, Carcinogenesis.

[76]  J. Woessner,et al.  Purification and Properties of Cathepsin D from Bovine Uterus , 1971 .

[77]  Soo-Youl Kim,et al.  Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1 , 1998, Experimental & Molecular Medicine.

[78]  B. Dunn,et al.  Aspartic Peptidase Inhibitors: Implications in Drug Development , 2003, Critical reviews in biochemistry and molecular biology.

[79]  K. Öllinger,et al.  Lysosomal membrane permeabilization during apoptosis ‐ involvement of Bax? , 2005, International journal of experimental pathology.

[80]  R. Nixon,et al.  Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[81]  G. Berchem,et al.  Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity , 2006, Oncogene.

[82]  V. Vetvicka,et al.  The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells. , 2008, International journal of oncology.

[83]  B. Posner,et al.  Proteolysis of Glucagon within Hepatic Endosomes by Membrane-associated Cathepsins B and D (*) , 1995, The Journal of Biological Chemistry.

[84]  A. Kimchi,et al.  Cathepsin D protease mediates programmed cell death induced by interferon‐gamma, Fas/APO‐1 and TNF‐alpha. , 1996, The EMBO journal.

[85]  K. Kato,et al.  Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. , 1988, Archives of biochemistry and biophysics.

[86]  J. Chirgwin,et al.  Role of glycosylation in the expression of human procathepsin D. , 1995, Journal of cell science.

[87]  B. Martin,et al.  Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. , 1997, Archives of biochemistry and biophysics.

[88]  V. Vetvicka,et al.  Possible role of procathepsin D in human cancer , 2008, Folia Microbiologica.

[89]  Y. Takei,et al.  Mitogenic activity toward human breast cancer cell line MCF-7 of two bFGFs purified from sera of breast cancer patients: co-operative role of cathepsin D , 1997, Breast Cancer Research and Treatment.

[90]  Bruno Martoglio,et al.  Aspartic proteases in drug discovery. , 2007, Current pharmaceutical design.

[91]  P. Codogno,et al.  Increase in Ceramide Level Alters the Lysosomal Targeting of Cathepsin D prior to Onset of Apoptosis in HT-29 Colon Cancer Cells , 2002, Biological chemistry.

[92]  V. Vetvicka,et al.  Analysis of the interaction of procathepsin D activation peptide with breast cancer cells , 1997, International journal of cancer.

[93]  P. Roughley The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan heterogeneity and the pathway of proteolytic degradation. , 1977, The Biochemical journal.

[94]  Z. Gokaslan,et al.  Expression of cathepsin D during the progression of human gliomas , 1996, Neuroscience Letters.

[95]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[96]  S. Singletary,et al.  Prognostic Factors in Node-Negative Breast Cancer: A Review of Studies With Sample Size More Than 200 and Follow-Up More Than 5 Years , 2002, Annals of surgery.

[97]  I. Touitou,et al.  Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction--single strand conformational polymorphism analysis and possible consequences in cancer cells. , 1994, European journal of cancer.

[98]  K. Kågedal,et al.  Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. , 2002, The American journal of pathology.

[99]  J. Vonsattel,et al.  Elevated Levels of the Endosomal‐Lysosomal Proteinase Cathepsin D in Cerebrospinal Fluid in Alzheimer Disease , 1995, Journal of neurochemistry.

[100]  V. Vetvicka,et al.  Role of procathepsin D activation peptide in prostate cancer growth , 2000, The Prostate.

[101]  A. Lajtha,et al.  Developmental changes in the breakdown of brain tubulin by cerebral cathepsin D , 2004, Neurochemical Research.

[102]  A. Lajtha,et al.  The breakdown of the individual neurofilament proteins by cathepsin D , 1987, Neurochemical Research.

[103]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[104]  G. Scambia,et al.  Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis. , 1997, British Journal of Cancer.

[105]  W. Lowther,et al.  Comparison of the active site specificity of the aspartic proteinases based on a systematic series of peptide substrates. , 1995, Advances in experimental medicine and biology.

[106]  V. Vetvicka,et al.  Procathepsin D in breast cancer: What do we know? Effects of ribozymes and other inhibitors , 2002, Cancer Gene Therapy.

[107]  P. Scott,et al.  Cathepsin D: Cleavage of soluble collagen and crosslinked peptides , 1978, FEBS letters.

[108]  A. Hasilik,et al.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. , 1980, The Journal of biological chemistry.

[109]  G. Johnson,et al.  A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. , 2006, Molecular genetics and metabolism.

[110]  S. Shangary,et al.  Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death , 2005, Molecular Cancer Therapeutics.

[111]  I. Christensen,et al.  Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. , 1989, Cancer research.

[112]  Wei Li,et al.  Induction of cell death by the lysosomotropic detergent MSDH , 2000, FEBS letters.

[113]  F. Harper,et al.  Cathepsin D Triggers Bax Activation, Resulting in Selective Apoptosis-inducing Factor (AIF) Relocation in T Lymphocytes Entering the Early Commitment Phase to Apoptosis* , 2003, Journal of Biological Chemistry.

[114]  C. Hallas,et al.  Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation , 2004, Cell Death and Differentiation.

[115]  H. Nakanishi,et al.  Cathepsin D Deficiency Induces Lysosomal Storage with Ceroid Lipofuscin in Mouse CNS Neurons , 2000, The Journal of Neuroscience.

[116]  F. Jessen,et al.  Contribution of Apolipoprotein E and Cathepsin D Genotypes to the Familial Aggregation of Alzheimer’s Disease , 2004, Dementia and Geriatric Cognitive Disorders.

[117]  Wei Li,et al.  Increased Expression and Translocation of Lysosomal Cathepsins Contribute to Macrophage Apoptosis in Atherogenesis , 2004, Annals of the New York Academy of Sciences.

[118]  A. Samarel,et al.  Effects of cysteine protease inhibitors on rabbit cathepsin D maturation. , 1989, The American journal of physiology.

[119]  G. Giaccone,et al.  Cell Death Independent of Caspases: A Review , 2005, Clinical Cancer Research.

[120]  K. Kato,et al.  Evidence that aspartic proteinase is involved in the proteolytic processing event of procathepsin L in lysosomes. , 1989, Archives of biochemistry and biophysics.

[121]  H. Nakanishi,et al.  Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice , 2003, Molecular and Cellular Neuroscience.

[122]  V. Laurent-Matha,et al.  Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. , 2006, Cancer letters.

[123]  J. Skepper,et al.  APOPTOSIS IN HUMAN MONOCYTE‐MACROPHAGES EXPOSED TO OXIDIZED LOW DENSITY LIPOPROTEIN , 1996, The Journal of pathology.

[124]  P. Steinert,et al.  Inactive zymogen and highly active proteolytically processed membrane-bound forms of the transglutaminase 1 enzyme in human epidermal keratinocytes. , 1996, Biochemical and biophysical research communications.

[125]  G. Conner,et al.  Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D. , 1992, Biochemistry.

[126]  V. Vetvicka,et al.  Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells. , 2006, Anticancer research.

[127]  H. Rochefort,et al.  MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. , 1991, Experimental cell research.

[128]  N. Gebbia,et al.  Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications , 2004, Clinical & Experimental Metastasis.

[129]  V. Vetvicka,et al.  Human procathepsin D: three-dimensional model and isolation. , 1995, Advances in experimental medicine and biology.

[130]  G. Kroemer,et al.  Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine , 2003, Oncogene.

[131]  F. Vizoso,et al.  Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer. , 2005, The International journal of biological markers.

[132]  G. Conner,et al.  Intermolecular association of lysosomal protein precursors during biosynthesis. , 1994, The Journal of biological chemistry.

[133]  V. Vetvicka,et al.  Effect of human procathepsin D on proliferation of human cell lines. , 1994, Cancer letters.

[134]  A. Hasilik,et al.  Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D , 2003, Cell Death and Differentiation.

[135]  M. DiFiglia,et al.  Lysosomal proteases are involved in generation of N-terminal huntingtin fragments , 2006, Neurobiology of Disease.

[136]  P. Kelly,et al.  A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. , 2006, Molecular endocrinology.

[137]  G. Rubin,et al.  Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses , 2005, Neurobiology of Disease.

[138]  M. Benuck,et al.  Metabolic instability of myelin proteins. Breakdown of basic protein induced by brain cathepsin D. , 1975, European journal of biochemistry.

[139]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[140]  T. Watanabe,et al.  Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. , 1998, Biochemical and biophysical research communications.

[141]  P. Pujol,et al.  Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. , 1990, Oncogene.

[142]  U. Brunk,et al.  OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. , 1998, Free radical research.

[143]  D. Kessel,et al.  Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage , 2002, Cell Death and Differentiation.

[144]  E. Ioachin Immunohistochemical tumour markers in endometrial carcinoma. , 2005, European journal of gynaecological oncology.

[145]  K. von Figura,et al.  Lysosomal enzymes and their receptors. , 1986, Annual review of biochemistry.

[146]  Y. Hannun,et al.  Ceramide in the eukaryotic stress response. , 2000, Trends in cell biology.

[147]  S. Mohammed,et al.  Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. , 2007, European journal of pharmacology.

[148]  C. Gerçel-Taylor,et al.  Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer. , 1999, Gynecologic oncology.

[149]  V. Vetvicka,et al.  Effect of procathepsin D and its activation peptide on prostate cancer cells. , 1998, Cancer letters.

[150]  T. Matsumoto,et al.  Purification of cathepsin D from rabbit skeletal muscle and its action towards myofibrils. , 1981, Biochimica et biophysica acta.

[151]  J. Ioannidis,et al.  Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. , 2004, American journal of epidemiology.

[152]  H. Tazaki,et al.  Hydrolysis of androgen receptor by cathepsin D: its biological significance in human prostate cancer. , 1998, British journal of urology.

[153]  T. Maudelonde,et al.  The Lancet: saturday 11 November 1989 , 1989 .

[154]  J. Martial,et al.  Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance. , 2004, Molecular endocrinology.

[155]  Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[156]  A. Zeiher,et al.  Cathepsin D and H2O2 Stimulate Degradation of Thioredoxin-1 , 2005, Journal of Biological Chemistry.

[157]  Carlo Follo,et al.  Cathepsin D-Bax death pathway in oxidative stressed neuroblastoma cells. , 2007, Free radical biology & medicine.

[158]  D. Selkoe Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[159]  G. Kroemer,et al.  Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion , 2003, The Journal of experimental medicine.

[160]  H. Rochefort,et al.  Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. , 1989, Cancer research.

[161]  A. Olsson,et al.  The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage. , 1997, Atherosclerosis.

[162]  N. Gebbia,et al.  Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications , 1993, Medicinal research reviews.

[163]  P. Stahl,et al.  Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. , 1989, The Journal of biological chemistry.

[164]  K. Blennow,et al.  The Cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease , 2006, Human mutation.

[165]  V. Vetvicka,et al.  Role of enzymatically inactive procathepsin D in lung cancer. , 2004, Anticancer research.

[166]  H. Rochefort,et al.  Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. , 1990, Molecular endocrinology.

[167]  W. Schneider-Brachert,et al.  Cathepsin D targeted by acid sphingomyelinase‐derived ceramide , 1999, The EMBO journal.

[168]  S. Yen,et al.  Oxidative stress‐induced phosphorylation, degradation and aggregation of α‐synuclein are linked to upregulated CK2 and cathepsin D , 2007, The European journal of neuroscience.

[169]  Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients , 1999, British Journal of Cancer.

[170]  A. Lehesjoki,et al.  Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. , 2006, Brain : a journal of neurology.

[171]  K. von Figura,et al.  Molecular forms of beta-hexosaminidase and cathepsin D in serum and urine of healthy subjects and patients with elevated activity of lysosomal enzymes. , 1983, The Biochemical journal.

[172]  L. B. Larsen,et al.  Identification of five molecular forms of cathepsin D in bovine milk. , 1995, Advances in experimental medicine and biology.

[173]  P. Vandenabeele,et al.  Non‐specific effects of methyl ketone peptide inhibitors of caspases , 1999, FEBS letters.

[174]  R. Maciewicz,et al.  Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D , 1996, International journal of cancer.

[175]  V. Vetvicka,et al.  Detection of procathepsin D in rat milk. , 2002, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[176]  J. Eaton,et al.  Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. , 2003, European journal of biochemistry.

[177]  T. Matsui,et al.  Mechanism of regulation of human epidermal transglutaminase. , 1981, The Journal of investigative dermatology.

[178]  C. Peters,et al.  Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D* , 1996, The Journal of Biological Chemistry.

[179]  J. Ježek,et al.  Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core. , 2006, Biochemistry.

[180]  V. Vetvicka,et al.  Procathepsin D secreted by HaCaT keratinocyte cells - A novel regulator of keratinocyte growth. , 2007, European journal of cell biology.

[181]  H. Geuze,et al.  Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells. , 1991, The Journal of biological chemistry.

[182]  P. Cohen,et al.  Acid‐activated insulin‐like growth factor binding protein protease activity of Cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma , 1997, Journal of cellular physiology.

[183]  G. Gores,et al.  Lysosomes in cell death , 2004, Oncogene.

[184]  U. Felbor,et al.  Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.

[185]  R. Sundler,et al.  Cytosolic pH regulation in mouse macrophages. Proton extrusion by plasma-membrane-localized H(+)-ATPase. , 1992, The Biochemical journal.

[186]  K. Öllinger,et al.  Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. , 1998, The American journal of pathology.

[187]  J. Olney,et al.  Cathepsin D Deficiency Induces Persistent Neurodegeneration in the Absence of Bax-Dependent Apoptosis , 2007, The Journal of Neuroscience.

[188]  Jinhe Li,et al.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.

[189]  S. Ishikawa,et al.  Angiostatin Generation by Cathepsin D Secreted by Human Prostate Carcinoma Cells* , 2000, The Journal of Biological Chemistry.

[190]  A. D. Dunn,et al.  Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L. , 1991, The Journal of biological chemistry.

[191]  P. Duchateau,et al.  Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects. , 1994, The Journal of biological chemistry.

[192]  C. Isidoro,et al.  Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions , 2004, Journal of Cell Science.

[193]  P. Scott,et al.  Cathepsin D: specificity of peptide-bond cleavage in type-I collagen and effects on type-III collagen and procollagen. , 2005, European journal of biochemistry.

[194]  V. Vetvicka,et al.  Effect of procathepsin D activation peptide on gene expression of breast cancer cells. , 2006, Cancer letters.

[195]  V. Vetvicka,et al.  Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines. , 2007, International journal of biological macromolecules.

[196]  G. Blobel,et al.  Biosynthesis of a lysosomal enzyme. Partial structure of two transient and functionally distinct NH2-terminal sequences in cathepsin D. , 1981, The Journal of biological chemistry.

[197]  J. Pauls,et al.  A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease , 2000, Annals of neurology.

[198]  H. Grosch,et al.  Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation. , 2004, The Biochemical journal.

[199]  K. von Figura,et al.  Processing of human cathepsin D in lysosomes in vitro. , 1985, The Journal of biological chemistry.

[200]  A. Hasilik,et al.  Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues. , 1980, The Journal of biological chemistry.

[201]  Katarina Kågedal,et al.  The FASEB Journal express article 10.1096/fj.00-0708fje. Published online May 18, 2001. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress , 2022 .

[202]  J. Loscalzo,et al.  The Macrophage and Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.

[203]  A. Paradiso,et al.  Release of the aspartyl protease cathepsin D is associated with and facilitates human breast cancer cell invasion , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[204]  D. Stover,et al.  Mechanisms and kinetics of procathepsin D activation. , 1999, European journal of biochemistry.

[205]  P. Pujol,et al.  Estrogens and epithelial ovarian cancer. , 2004, Gynecologic oncology.

[206]  C. Peters,et al.  Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). , 2005, The American journal of pathology.

[207]  J. Loscalzo,et al.  The fibrin(ogen)olytic properties of cathepsin D. , 1994, Biochemistry.

[208]  B. Björkerud,et al.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.

[209]  K. Hara,et al.  Processing of cathepsins L, B and D in psoriatic epidermis , 1997, Archives of Dermatological Research.

[210]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[211]  J. Shively,et al.  Human placental fibronectin: demonstration of structural differences between the A and B chains in the extra domain-A region. , 1988, Archives of biochemistry and biophysics.

[212]  C. Peters,et al.  Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity , 1998, Oncogene.

[213]  Fernández,et al.  Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma , 1999, Histopathology.